Filing Flows › Vaxart (VXRT) › Recalls, complaints & regulation
Vaxart (VXRT): clinical trials
Vaxart (VXRT) beyond its filings: 1 active clinical trial.
Vaxart's latest quarter
Vaxart, Q3 2026: revenue $10.6M (-85% year over year), operating margin -162.7%, net loss $17.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Vaxart have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.